Last update 15 Jun 2025
Purinomia Biotech, Inc.

Purinomia Biotech, Inc.

Startups
| Private Company|2017|Massachusetts, United States|
10-50
|
purinomia.com

Overview

Tags

Other Diseases
Neoplasms
Immune System Diseases
Biological products

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Immune System Diseases1
Top 5 Drug TypeCount
Biological products2
Unknown1
Top 5 TargetCount
CD39(Ectonucleoside triphosphate diphosphohydrolase 1)1

Related

3
Drugs associated with Purinomia Biotech, Inc.
PUR-004
Target
CD39
Mechanism
CD39 inhibitors
Active Org.
Purinomia Biotech, Inc.Purinomia Biotech, Inc.
Originator Org.
Purinomia Biotech, Inc.Purinomia Biotech, Inc.
Active Indication
Autoimmune Diseases [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
PUR-003(Purinomia Biotech)
Target-
Mechanism-
Active Org.
Purinomia Biotech, Inc.Purinomia Biotech, Inc.
Originator Org.
Purinomia Biotech, Inc.Purinomia Biotech, Inc.
Active Indication
Inflammation
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
PUR-002
Target-
Mechanism-
Active Org.
Purinomia Biotech, Inc.Purinomia Biotech, Inc.
Originator Org.
Purinomia Biotech, Inc.Purinomia Biotech, Inc.
Active Indication
Solid tumor
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Purinomia Biotech, Inc.
NCT05234853
/ Unknown statusPhase 1
A Phase I, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of PUR001 Administered Intravenously in Adult Patients With Advanced Solid Tumors
100 Clinical Results associated with Purinomia Biotech, Inc.
Login to view more data
0 Patents (Medical) associated with Purinomia Biotech, Inc.
Login to view more data
100 Deals associated with Purinomia Biotech, Inc.
Login to view more data
100 Translational Medicine associated with Purinomia Biotech, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
PUR-004
 ( CD39 )		Autoimmune Diseases
More
Preclinical
PUR-002
Solid tumor
More
Preclinical
PUR-003(Purinomia Biotech)
Inflammation
More
Preclinical
PUR-001
 ( CD39 )		Advanced Malignant Solid Neoplasm
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free